An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

ONE of the drugs most commonly employed for the management of atrial fibrillation is quinidine. Its use was demonstrated as early as 1918 by Frey. 1 The compound, a cinchona alkaloid and the d ...

After two years, Alberta will become the first province in Canada to allow forced drug-addiction treatment You can save this article by registering for free here. Or sign-in if you have an account.

Systemic lupus erythematosus (SLE) is an autoimmune disease, which is characterised by overactivation of the immune system and involvement of various organs such as kidney and brain. Despite advances ...

Instead, I am headed to my doctor to discuss how this happened, what testing is needed and what this means for my new treatment plan. Sounds like chemo is off the table now.” She confirmed on ...

They'll assess your mobility and the type of movement that causes pain. Treatment for pseudoarthrosis will likely start with medication, physical therapy, injections, or pain management, especially in ...

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive ... and inflammatory causes (Table ...

is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 with the infusion of the 81st patient ...

Conclusion Rituximab was effective and well-tolerated for the treatment of SLE, which had a low incidence of adverse events. Reference [1]Wise LM, Stohl W. Belimumab and Rituximab in Systemic Lupus ...